139 related articles for article (PubMed ID: 21727058)
1. Effects of cyclosporine on pruritus and serum IL-31 levels in patients with atopic dermatitis.
Otsuka A; Tanioka M; Nakagawa Y; Honda T; Ikoma A; Miyachi Y; Kabashima K
Eur J Dermatol; 2011; 21(5):816-7. PubMed ID: 21727058
[No Abstract] [Full Text] [Related]
2. Decrease in serum IL-32 level in patients with atopic dermatitis after cyclosporine treatment.
Kitayama N; Otsuka A; Nonomura Y; Nakashima C; Honda T; Kabashima K
J Eur Acad Dermatol Venereol; 2017 Oct; 31(10):e449-e450. PubMed ID: 28403511
[No Abstract] [Full Text] [Related]
3. An H1-histamine receptor antagonist decreases serum interleukin-31 levels in patients with atopic dermatitis.
Otsuka A; Honda T; Doi H; Miyachi Y; Kabashima K
Br J Dermatol; 2011 Feb; 164(2):455-6. PubMed ID: 21039403
[No Abstract] [Full Text] [Related]
4. The efficacy of cyclosporine A in cats with presumed atopic dermatitis: a double blind, randomised prednisolone-controlled study.
Wisselink MA; Willemse T
Vet J; 2009 Apr; 180(1):55-9. PubMed ID: 18294881
[TBL] [Abstract][Full Text] [Related]
5. Combination of glucosamine and low-dose cyclosporine for atopic dermatitis treatment: a randomized, placebo-controlled, double-blind, parallel clinical trial.
Jin SY; Lim WS; Sung NH; Cheong KA; Lee AY
Dermatol Ther; 2015; 28(1):44-51. PubMed ID: 25113885
[TBL] [Abstract][Full Text] [Related]
6. In the management of mild to moderate atopic dermatitis in adults.
Recchia M
J Drugs Dermatol; 2007 Mar; 6(3):252; author reply 252. PubMed ID: 17373186
[No Abstract] [Full Text] [Related]
7. Treatment of pruritus in mild-to-moderate atopic dermatitis with a topical non-steroidal agent.
Veraldi S; De Micheli P; Schianchi R; Lunardon L
J Drugs Dermatol; 2009 Jun; 8(6):537-9. PubMed ID: 19537379
[TBL] [Abstract][Full Text] [Related]
8. Treatment of canine atopic dermatitis with cyclosporine: a pilot clinical study.
Fontaine J; Olivry T
Vet Rec; 2001 May; 148(21):662-3. PubMed ID: 11400987
[No Abstract] [Full Text] [Related]
9. Significant correlation of serum IL-22 levels with CCL17 levels in atopic dermatitis.
Hayashida S; Uchi H; Takeuchi S; Esaki H; Moroi Y; Furue M
J Dermatol Sci; 2011 Jan; 61(1):78-9. PubMed ID: 21095106
[No Abstract] [Full Text] [Related]
10. The frequencies of haplotypes defined by three polymorphisms of the IL-31 gene: -1066, -2057, and IVS2+12 in Polish patients with atopic dermatitis.
Sokołowska-Wojdyło M; Gleń J; Zabłotna M; Rębała K; Trzeciak M; Sikorska M; Ruckemann-Dziurdzińska K; Nedoszytko B; Florek A; Nowicki R
Int J Dermatol; 2015 Jan; 54(1):62-7. PubMed ID: 25534405
[TBL] [Abstract][Full Text] [Related]
11. Successful cyclosporine treatment for atopic dermatitis in a rhesus macaque (Macaca mulatta).
Ovadia S; Wilson SR; Zeiss CJ
Comp Med; 2005 Apr; 55(2):192-6. PubMed ID: 15884783
[TBL] [Abstract][Full Text] [Related]
12. Naphthalene in the treatment of patients with atopic dermatitis.
Smeh-Skrbin A; Dobrić I; Krnjević-Pezić G; Vrzogić P
Acta Dermatovenerol Croat; 2007; 15(1):15-9. PubMed ID: 17433174
[TBL] [Abstract][Full Text] [Related]
13. Serum measurement of interleukin-31 (IL-31) in paediatric atopic dermatitis: elevated levels correlate with severity scoring.
Ezzat MH; Hasan ZE; Shaheen KY
J Eur Acad Dermatol Venereol; 2011 Mar; 25(3):334-9. PubMed ID: 21294778
[TBL] [Abstract][Full Text] [Related]
14. Serum thymus and activation-regulated chemokine (TARC) and interleukin-31 levels as biomarkers for monitoring in adult atopic dermatitis.
Kyoya M; Kawakami T; Soma Y
J Dermatol Sci; 2014 Sep; 75(3):204-7. PubMed ID: 24984931
[No Abstract] [Full Text] [Related]
15. Significance of interleukin-16, macrophage-derived chemokine, eosinophil cationic protein and soluble E-selectin in reflecting disease activity of atopic dermatitis--from laboratory parameters to clinical scores.
Angelova-Fischer I; Hipler UC; Bauer A; Fluhr JW; Tsankov N; Fischer TW; Elsner P
Br J Dermatol; 2006 Jun; 154(6):1112-7. PubMed ID: 16704642
[TBL] [Abstract][Full Text] [Related]
16. Serum interleukin-31 level and pruritus in atopic dermatitis: A Meta-analysis.
Lu J; Wu K; Zeng Q; Xiang Y; Gao L; Huang J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Feb; 43(2):124-130. PubMed ID: 29559593
[TBL] [Abstract][Full Text] [Related]
17. Possible Antipruritic Mechanism of Cyclosporine A in Atopic Dermatitis.
Ko KC; Tominaga M; Kamata Y; Umehara Y; Matsuda H; Takahashi N; Kina K; Ogawa M; Ogawa H; Takamori K
Acta Derm Venereol; 2016 Jun; 96(5):624-9. PubMed ID: 26671728
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the antipruritic efficacy of hydroxyzine and cyproheptadine in children with atopic dermatitis.
Klein GL; Galant SP
Ann Allergy; 1980 Mar; 44(3):142-5. PubMed ID: 7362092
[No Abstract] [Full Text] [Related]
19. Long-term use of cyclosporine in the treatment of canine atopic dermatitis.
Radowicz SN; Power HT
Vet Dermatol; 2005 Apr; 16(2):81-6. PubMed ID: 15842537
[TBL] [Abstract][Full Text] [Related]
20. Assessing the effects of topical cannabidiol in patients with atopic dermatitis.
Maghfour J; Rundle CW; Rietcheck HR; Dercon S; Lio P; Mamo A; Runion TM; Fernandez J; Kahn J; Dellavalle RP; Yardley H
Dermatol Online J; 2021 Feb; 27(2):. PubMed ID: 33818989
[No Abstract] [Full Text] [Related]
[Next] [New Search]
